137 related articles for article (PubMed ID: 35248720)
21. Retinoic Acid Facilitates Toll-Like Receptor 4 Expression to Improve Intestinal Barrier Function through Retinoic Acid Receptor Beta.
Li Y; Gao Y; Cui T; Yang T; Liu L; Li T; Chen J
Cell Physiol Biochem; 2017; 42(4):1390-1406. PubMed ID: 28715808
[TBL] [Abstract][Full Text] [Related]
22. A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis.
Petty WJ; Li N; Biddle A; Bounds R; Nitkin C; Ma Y; Dragnev KH; Freemantle SJ; Dmitrovsky E
J Natl Cancer Inst; 2005 Nov; 97(22):1645-51. PubMed ID: 16288117
[TBL] [Abstract][Full Text] [Related]
23. Anticancer effect of retinoic acid via AP-1 activity repression is mediated by retinoic acid receptor alpha and beta in gastric cancer cells.
Wu Q; Chen ZM; Su WJ
Int J Biochem Cell Biol; 2002 Sep; 34(9):1102-14. PubMed ID: 12009305
[TBL] [Abstract][Full Text] [Related]
24. TET2-BCLAF1 transcription repression complex epigenetically regulates the expression of colorectal cancer gene Ascl2 via methylation of its promoter.
Shang Y; Jiang T; Ran L; Hu W; Wu Y; Ye J; Peng Z; Chen L; Wang R
J Biol Chem; 2022 Jul; 298(7):102095. PubMed ID: 35660018
[TBL] [Abstract][Full Text] [Related]
25. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.
Fang MZ; Chen D; Sun Y; Jin Z; Christman JK; Yang CS
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):7033-41. PubMed ID: 16203797
[TBL] [Abstract][Full Text] [Related]
26. Associations of RASSF1A, RARβ, and CDH1 promoter hypermethylation with oral cancer risk: A PRISMA-compliant meta-analysis.
Wen G; Wang H; Zhong Z
Medicine (Baltimore); 2018 Mar; 97(11):e9971. PubMed ID: 29538221
[TBL] [Abstract][Full Text] [Related]
27. Methylation status of SFRP1, SFRP2, RASSF1A, RARβ and DAPK1 genes in patients with oral squamous cell carcinoma.
Strzelczyk JK; Krakowczyk Ł; Owczarek AJ
Arch Oral Biol; 2019 Feb; 98():265-272. PubMed ID: 30576962
[TBL] [Abstract][Full Text] [Related]
28. Demethylation by 5-aza-2'-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells.
Côté S; Sinnett D; Momparler RL
Anticancer Drugs; 1998 Oct; 9(9):743-50. PubMed ID: 9840718
[TBL] [Abstract][Full Text] [Related]
29. Clinically relevant aberrant Filip1l DNA methylation detected in a murine model of cutaneous squamous cell carcinoma.
Roth K; Coussement L; Knatko EV; Higgins M; Steyaert S; Proby CM; de Meyer T; Dinkova-Kostova AT
EBioMedicine; 2021 May; 67():103383. PubMed ID: 34000624
[TBL] [Abstract][Full Text] [Related]
30. Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing.
Shaw RJ; Liloglou T; Rogers SN; Brown JS; Vaughan ED; Lowe D; Field JK; Risk JM
Br J Cancer; 2006 Feb; 94(4):561-8. PubMed ID: 16449996
[TBL] [Abstract][Full Text] [Related]
31. Loss of retinoic acid receptor beta gene expression is linked to aberrant histone H3 acetylation in lung cancer cell lines.
Suh YA; Lee HY; Virmani A; Wong J; Mann KK; Miller WH; Gazdar A; Kurie JM
Cancer Res; 2002 Jul; 62(14):3945-9. PubMed ID: 12124324
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic regulation of Myc on retinoic acid receptor beta and PDLIM4 in RWPE1 cells.
He M; Vanaja DK; Karnes RJ; Young CY
Prostate; 2009 Nov; 69(15):1643-50. PubMed ID: 19623543
[TBL] [Abstract][Full Text] [Related]
33. Synergistic effects of retinoic acid and 8-chloro-adenosine 3',5'-cyclic monophosphate on the regulation of retinoic acid receptor beta and apoptosis: involvement of mitochondria.
Srivastava RK; Srivastava AR; Cho-Chung YS; Longo DL
Clin Cancer Res; 1999 Jul; 5(7):1892-904. PubMed ID: 10430097
[TBL] [Abstract][Full Text] [Related]
34. CRABP-II- and FABP5-independent all-trans retinoic acid resistance in COLO 16 human cutaneous squamous cancer cells.
Chen NN; Li Y; Wu ML; Liu ZL; Fu YS; Kong QY; Chen XY; Li H; Liu J
Exp Dermatol; 2012 Jan; 21(1):13-8. PubMed ID: 22082219
[TBL] [Abstract][Full Text] [Related]
35. A novel RARbeta isoform directed by a distinct promoter P3 and mediated by retinoic acid in breast cancer cells.
Peng X; Maruo T; Cao Y; Punj V; Mehta R; Das Gupta TK; Christov K
Cancer Res; 2004 Dec; 64(24):8911-8. PubMed ID: 15604252
[TBL] [Abstract][Full Text] [Related]
36. Retinoic Acid Receptor β: A Potential Therapeutic Target in Retinoic Acid Treatment of Endometrial Cancer.
Tsuji K; Utsunomiya H; Miki Y; Hanihara M; Fue M; Takagi K; Nishimoto M; Suzuki F; Yaegashi N; Suzuki T; Ito K
Int J Gynecol Cancer; 2017 May; 27(4):643-650. PubMed ID: 28375930
[TBL] [Abstract][Full Text] [Related]
37. Promoter hypermethylation profile of ovarian epithelial neoplasms.
Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
[TBL] [Abstract][Full Text] [Related]
38. RARβ Promoter Methylation as an Epigenetic Mechanism of Gene Silencing in Non-small Cell Lung Cancer.
Dutkowska A; Antczak A; Pastuszak-Lewandoska D; Migdalska-Sek M; Czarnecka KH; Górski P; Kordiak J; Nawrot E; Brzeziańska-Lasota E
Adv Exp Med Biol; 2016; 878():29-38. PubMed ID: 26453065
[TBL] [Abstract][Full Text] [Related]
39. [Recombinant adenovirus expressing siRNA is generated to inhibit the expression of RARbeta in rat mesenchymal stem cells treated by all-trans retinoic acid].
Bi Y; Gong M; He Y; Zhang Y; Chen J; Li T
Sheng Wu Gong Cheng Xue Bao; 2012 May; 28(5):632-42. PubMed ID: 22916501
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids.
Wu Q; Dawson MI; Zheng Y; Hobbs PD; Agadir A; Jong L; Li Y; Liu R; Lin B; Zhang XK
Mol Cell Biol; 1997 Nov; 17(11):6598-608. PubMed ID: 9343423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
